JP2024534348A5 - - Google Patents
Info
- Publication number
- JP2024534348A5 JP2024534348A5 JP2024515564A JP2024515564A JP2024534348A5 JP 2024534348 A5 JP2024534348 A5 JP 2024534348A5 JP 2024515564 A JP2024515564 A JP 2024515564A JP 2024515564 A JP2024515564 A JP 2024515564A JP 2024534348 A5 JP2024534348 A5 JP 2024534348A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- sequence number
- includes sequence
- sequence includes
- tau
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025115822A JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163242437P | 2021-09-09 | 2021-09-09 | |
| US63/242,437 | 2021-09-09 | ||
| PCT/US2022/042963 WO2023039107A2 (en) | 2021-09-09 | 2022-09-08 | Phospho-tau antibodies and methods of use |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025115822A Division JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A Division JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534348A JP2024534348A (ja) | 2024-09-20 |
| JP2024534348A5 true JP2024534348A5 (enExample) | 2025-07-17 |
| JP7836885B2 JP7836885B2 (ja) | 2026-03-27 |
Family
ID=85507770
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515564A Active JP7836885B2 (ja) | 2021-09-09 | 2022-09-08 | ホスホ－タウ抗体および使用の方法 |
| JP2025115822A Active JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A Pending JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025115822A Active JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A Pending JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US12276671B2 (enExample) |
| EP (1) | EP4399524A4 (enExample) |
| JP (3) | JP7836885B2 (enExample) |
| KR (2) | KR102888596B1 (enExample) |
| CN (1) | CN118235043A (enExample) |
| CA (1) | CA3231228A1 (enExample) |
| WO (1) | WO2023039107A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7836885B2 (ja) | 2021-09-09 | 2026-03-27 | アルツパス， インコーポレイテッド | ホスホ－タウ抗体および使用の方法 |
| EP4680633A1 (en) * | 2023-03-16 | 2026-01-21 | Alzpath, Inc. | Methods of diagnosing and treating neurodegenerative disorders |
| CN119470917A (zh) * | 2024-11-14 | 2025-02-18 | 苏州智研医康医疗科技有限公司 | 一种检测人血中阿尔茨海默病相关蛋白的试剂盒及检测方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4694778A (en) | 1984-05-04 | 1987-09-22 | Anicon, Inc. | Chemical vapor deposition wafer boat |
| US20040219509A1 (en) | 2001-08-20 | 2004-11-04 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US7604956B2 (en) | 2004-03-01 | 2009-10-20 | Biotraces, Inc. | Supersensitive immunoassays |
| ES2367311T3 (es) | 2004-04-15 | 2011-11-02 | University Of Florida Research Foundation, Inc. | Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales. |
| JP2011508219A (ja) | 2007-12-19 | 2011-03-10 | シンギュレックス・インコーポレイテッド | 単一分子検出走査分析器およびその使用方法 |
| US20110177509A1 (en) | 2008-07-23 | 2011-07-21 | The Washington University | Risk factors and a therapeutic target for neurodegenerative disorders |
| AU2010259022B2 (en) | 2009-06-08 | 2016-05-12 | Singulex, Inc. | Highly sensitive biomarker panels |
| AU2011215970A1 (en) * | 2010-02-09 | 2012-09-20 | Bristol-Myers Squibb Company | Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards |
| WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
| WO2012142300A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury resulting from a hypoxic event |
| GB201112056D0 (en) | 2011-07-14 | 2011-08-31 | Univ Leuven Kath | Antibodies |
| ES2600915T3 (es) | 2011-10-07 | 2017-02-13 | Ac Immune S.A. | Anticuerpos fosfoespecíficos que reconocen Tau |
| PT2794654T (pt) | 2011-12-20 | 2019-09-10 | Janssen Biotech Inc | Anticorpos anti-phf-tau e suas utilizações |
| DK2885010T3 (da) | 2012-08-16 | 2020-02-03 | Ipierian Inc | Fremgangsmåder til behandling med tauopati |
| AR100978A1 (es) * | 2014-06-26 | 2016-11-16 | Hoffmann La Roche | LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS |
| UA126272C2 (uk) * | 2015-06-05 | 2022-09-14 | Дженентек, Інк. | Антитіло проти тау-білка та спосіб його застосування |
| GB201518675D0 (en) * | 2015-10-21 | 2015-12-02 | Cellcap Technologies Ltd | Detection of structural forms of proteins |
| US20180080945A1 (en) * | 2016-09-20 | 2018-03-22 | Nanosomix, Inc. | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders |
| KR102048987B1 (ko) * | 2017-02-22 | 2019-11-27 | 한국과학기술연구원 | 신경퇴행성 장애의 진단을 위한 정보 제공 방법 |
| JP7029718B2 (ja) * | 2017-07-31 | 2022-03-04 | 国立研究開発法人量子科学技術研究開発機構 | リン酸化タウタンパク質の測定方法 |
| CN109932509B (zh) | 2017-11-02 | 2021-08-24 | 和其瑞医药(南京)有限公司 | 检测或抑制细胞外游离mg53的方法和用途 |
| US11591385B2 (en) | 2017-11-09 | 2023-02-28 | Pinteon Therapeutics Inc. | Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies |
| US20200377609A1 (en) | 2018-02-14 | 2020-12-03 | Kite Pharma, Inc. | Anti-idiotypic antibodies directed to the antigen-binding portion of an bcma-binding molecule |
| US20220018856A1 (en) | 2018-11-22 | 2022-01-20 | Fujirebio Inc. | Antibody conjugate |
| CA3297188A1 (en) | 2019-05-31 | 2026-03-02 | Eli Lilly And Company | Compounds and methods targeting human tau |
| US20210285965A1 (en) | 2020-03-03 | 2021-09-16 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Proteomic screening for diseases |
| CN112505322A (zh) | 2020-10-16 | 2021-03-16 | 威海纽普生物技术有限公司 | 阿尔茨海默病标志物p-Tau217检测试剂盒及其制造方法 |
| WO2022115705A2 (en) | 2020-11-30 | 2022-06-02 | Enigma Biointelligence, Inc. | Non-invasive assessment of alzheimer's disease |
| TWI843040B (zh) | 2021-01-11 | 2024-05-21 | 美商美國禮來大藥廠 | 抗N3pGlu類澱粉β抗體及其用途 |
| JP7836885B2 (ja) | 2021-09-09 | 2026-03-27 | アルツパス， インコーポレイテッド | ホスホ－タウ抗体および使用の方法 |
| EP4680633A1 (en) | 2023-03-16 | 2026-01-21 | Alzpath, Inc. | Methods of diagnosing and treating neurodegenerative disorders |
-
2022
- 2022-09-08 JP JP2024515564A patent/JP7836885B2/ja active Active
- 2022-09-08 EP EP22868084.9A patent/EP4399524A4/en active Pending
- 2022-09-08 KR KR1020257022547A patent/KR102888596B1/ko active Active
- 2022-09-08 WO PCT/US2022/042963 patent/WO2023039107A2/en not_active Ceased
- 2022-09-08 CA CA3231228A patent/CA3231228A1/en active Pending
- 2022-09-08 CN CN202280074834.XA patent/CN118235043A/zh active Pending
- 2022-09-08 KR KR1020247011209A patent/KR102959196B1/ko active Active
-
2024
- 2024-03-08 US US18/599,751 patent/US12276671B2/en active Active
- 2024-07-11 US US18/770,102 patent/US12339290B2/en active Active
-
2025
- 2025-05-16 US US19/210,582 patent/US20250277799A1/en active Pending
- 2025-07-09 JP JP2025115822A patent/JP7828500B2/ja active Active
- 2025-12-08 JP JP2025239499A patent/JP2026034506A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114751981B (zh) | 抗SARS-CoV-2核衣壳蛋白的单克隆抗体及其应用 | |
| JP2016505634A5 (enExample) | ||
| CN116082498A (zh) | 一种猴痘病毒蛋白的单克隆抗体及其应用 | |
| JP2015527365A5 (enExample) | ||
| JP2015531768A5 (enExample) | ||
| JP2015502752A5 (enExample) | ||
| JP2019504013A5 (enExample) | ||
| JP2014518624A5 (enExample) | ||
| KR102426782B1 (ko) | SARS-CoV-2 RBD 항원 특이적 항체를 포함하는 진단용 조성물 또는 키트 | |
| JP7836885B2 (ja) | ホスホ－タウ抗体および使用の方法 | |
| KR101192130B1 (ko) | 비브리오균의 외막단백질에 대한 항체 및 이를 이용한 상기 균의 검출 방법 | |
| JP5821198B2 (ja) | 抗ｉｌ２８ｂ抗体及びこれを用いたｉｌ２８ｂの測定方法 | |
| CN116284368A (zh) | 抗人MxA抗体或其抗原结合部分 | |
| CN106939034A (zh) | 用于鉴定受试者所感染的hev基因型的方法和试剂盒 | |
| KR102709435B1 (ko) | SARS-CoV-2 특이적 신규 항체를 이용한 SARS-CoV-2의 검출방법 | |
| JPWO2024070874A5 (enExample) | ||
| CN118440188A (zh) | 抗新型冠状病毒或其n蛋白抗体、检测新型冠状病毒或其n蛋白的试剂和试剂盒 | |
| CN116120440A (zh) | 抗SARS-CoV-2刺突蛋白S1的单克隆抗体及其应用 | |
| JP2024544885A5 (enExample) | ||
| EP3177312B1 (en) | Method and kit for detecting bacterial infection | |
| JP2018027024A (ja) | アプタマー及び抗体検出方法 | |
| KR102798975B1 (ko) | 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도 | |
| KR102798983B1 (ko) | 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도 | |
| EP3857225B1 (en) | Complex stabilizing components and detection methods thereof | |
| KR102798934B1 (ko) | 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도 |